Douglas Lane & Associates, LLC Zoetis Inc. Transaction History
Douglas Lane & Associates, LLC
- $6.9 Billion
- Q3 2025
A detailed history of Douglas Lane & Associates, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 306,753 shares of ZTS stock, worth $36.4 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
306,753
Previous 226,847
35.22%
Holding current value
$36.4 Million
Previous $35.4 Million
26.88%
% of portfolio
0.65%
Previous 0.53%
Shares
34 transactions
Others Institutions Holding ZTS
# of Institutions
2,082Shares Held
423MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...